share_log

上海医药:X842项目获药品注册证书

Sh Pharma: X842 project obtains pharmaceutical registration certificate.

Breakings ·  Dec 4 15:32

Sh Pharma announced that its wholly-owned subsidiary, Shanghai Sh Pharmaceutical Xinyi Pharmaceutical Factory Co., Ltd., in cooperation with Guizhou Senova Bio-Technology Co., Ltd., has obtained the "Pharmaceutical Registration Certificate" issued by the National Medical Products Administration. The X842 project is a type 1 new generation potassium ion competitive acid blocker oral drug intended for the treatment of reflux esophagitis.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment